The global market for Molecular Diagnosis of Tumors was valued at US$ 1771 million in the year 2024 and is projected to reach a revised size of US$ 3334 million by 2031, growing at a CAGR of 9.6% during the forecast period.

Molecular Diagnosis of Tumors Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Molecular Diagnosis of Tumors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnosis of Tumors.

The Molecular Diagnosis of Tumors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Diagnosis of Tumors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Molecular Diagnosis of Tumors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Molecular Diagnosis of Tumors Market Report

Report Metric	Details
Report Name	Molecular Diagnosis of Tumors Market
Accounted market size in year	US$ 1771 million
Forecasted market size in 2031	US$ 3334 million
CAGR	9.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	NGS-Based PCR-Based
Segment by Application	Hospitals Diagnostic Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Roche Holding, Thermo Fisher Scientific, Danaher Corporation, Veracyte, TBG Diagnostics, Agilient Technologies, Illumina, Genecast, Burning Rock Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnosis of Tumors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Molecular Diagnosis of Tumors Market growing?

Ans: The Molecular Diagnosis of Tumors Market witnessing a CAGR of 9.6% during the forecast period 2025-2031.

What is the Molecular Diagnosis of Tumors Market size in 2031?

Ans: The Molecular Diagnosis of Tumors Market size in 2031 will be US$ 3334 million.

Who are the main players in the Molecular Diagnosis of Tumors Market report?

Ans: The main players in the Molecular Diagnosis of Tumors Market are Abbott Laboratories, Roche Holding, Thermo Fisher Scientific, Danaher Corporation, Veracyte, TBG Diagnostics, Agilient Technologies, Illumina, Genecast, Burning Rock Biotech

What are the Application segmentation covered in the Molecular Diagnosis of Tumors Market report?

Ans: The Applications covered in the Molecular Diagnosis of Tumors Market report are Hospitals, Diagnostic Centers, Others

What are the Type segmentation covered in the Molecular Diagnosis of Tumors Market report?

Ans: The Types covered in the Molecular Diagnosis of Tumors Market report are NGS-Based, PCR-Based

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Diagnosis of Tumors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 NGS-Based

1.2.3 PCR-Based

1.3 Market by Application

1.3.1 Global Molecular Diagnosis of Tumors Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Diagnosis of Tumors Market Perspective (2020-2031)

2.2 Global Molecular Diagnosis of Tumors Growth Trends by Region

2.2.1 Global Molecular Diagnosis of Tumors Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Molecular Diagnosis of Tumors Historic Market Size by Region (2020-2025)

2.2.3 Molecular Diagnosis of Tumors Forecasted Market Size by Region (2026-2031)

2.3 Molecular Diagnosis of Tumors Market Dynamics

2.3.1 Molecular Diagnosis of Tumors Industry Trends

2.3.2 Molecular Diagnosis of Tumors Market Drivers

2.3.3 Molecular Diagnosis of Tumors Market Challenges

2.3.4 Molecular Diagnosis of Tumors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Diagnosis of Tumors Players by Revenue

3.1.1 Global Top Molecular Diagnosis of Tumors Players by Revenue (2020-2025)

3.1.2 Global Molecular Diagnosis of Tumors Revenue Market Share by Players (2020-2025)

3.2 Global Molecular Diagnosis of Tumors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Molecular Diagnosis of Tumors Revenue

3.4 Global Molecular Diagnosis of Tumors Market Concentration Ratio

3.4.1 Global Molecular Diagnosis of Tumors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Tumors Revenue in 2024

3.5 Global Key Players of Molecular Diagnosis of Tumors Head office and Area Served

3.6 Global Key Players of Molecular Diagnosis of Tumors, Product and Application

3.7 Global Key Players of Molecular Diagnosis of Tumors, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnosis of Tumors Breakdown Data by Type

4.1 Global Molecular Diagnosis of Tumors Historic Market Size by Type (2020-2025)

4.2 Global Molecular Diagnosis of Tumors Forecasted Market Size by Type (2026-2031)

5 Molecular Diagnosis of Tumors Breakdown Data by Application

5.1 Global Molecular Diagnosis of Tumors Historic Market Size by Application (2020-2025)

5.2 Global Molecular Diagnosis of Tumors Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Molecular Diagnosis of Tumors Market Size (2020-2031)

6.2 North America Molecular Diagnosis of Tumors Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Molecular Diagnosis of Tumors Market Size by Country (2020-2025)

6.4 North America Molecular Diagnosis of Tumors Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Molecular Diagnosis of Tumors Market Size (2020-2031)

7.2 Europe Molecular Diagnosis of Tumors Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Molecular Diagnosis of Tumors Market Size by Country (2020-2025)

7.4 Europe Molecular Diagnosis of Tumors Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Molecular Diagnosis of Tumors Market Size (2020-2031)

8.2 Asia-Pacific Molecular Diagnosis of Tumors Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region (2020-2025)

8.4 Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Molecular Diagnosis of Tumors Market Size (2020-2031)

9.2 Latin America Molecular Diagnosis of Tumors Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Molecular Diagnosis of Tumors Market Size by Country (2020-2025)

9.4 Latin America Molecular Diagnosis of Tumors Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Diagnosis of Tumors Market Size (2020-2031)

10.2 Middle East & Africa Molecular Diagnosis of Tumors Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country (2020-2025)

10.4 Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Molecular Diagnosis of Tumors Introduction

11.1.4 Abbott Laboratories Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.1.5 Abbott Laboratories Recent Development

11.2 Roche Holding

11.2.1 Roche Holding Company Details

11.2.2 Roche Holding Business Overview

11.2.3 Roche Holding Molecular Diagnosis of Tumors Introduction

11.2.4 Roche Holding Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.2.5 Roche Holding Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Molecular Diagnosis of Tumors Introduction

11.3.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Danaher Corporation

11.4.1 Danaher Corporation Company Details

11.4.2 Danaher Corporation Business Overview

11.4.3 Danaher Corporation Molecular Diagnosis of Tumors Introduction

11.4.4 Danaher Corporation Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.4.5 Danaher Corporation Recent Development

11.5 Veracyte

11.5.1 Veracyte Company Details

11.5.2 Veracyte Business Overview

11.5.3 Veracyte Molecular Diagnosis of Tumors Introduction

11.5.4 Veracyte Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.5.5 Veracyte Recent Development

11.6 TBG Diagnostics

11.6.1 TBG Diagnostics Company Details

11.6.2 TBG Diagnostics Business Overview

11.6.3 TBG Diagnostics Molecular Diagnosis of Tumors Introduction

11.6.4 TBG Diagnostics Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.6.5 TBG Diagnostics Recent Development

11.7 Agilient Technologies

11.7.1 Agilient Technologies Company Details

11.7.2 Agilient Technologies Business Overview

11.7.3 Agilient Technologies Molecular Diagnosis of Tumors Introduction

11.7.4 Agilient Technologies Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.7.5 Agilient Technologies Recent Development

11.8 Illumina

11.8.1 Illumina Company Details

11.8.2 Illumina Business Overview

11.8.3 Illumina Molecular Diagnosis of Tumors Introduction

11.8.4 Illumina Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.8.5 Illumina Recent Development

11.9 Genecast

11.9.1 Genecast Company Details

11.9.2 Genecast Business Overview

11.9.3 Genecast Molecular Diagnosis of Tumors Introduction

11.9.4 Genecast Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.9.5 Genecast Recent Development

11.10 Burning Rock Biotech

11.10.1 Burning Rock Biotech Company Details

11.10.2 Burning Rock Biotech Business Overview

11.10.3 Burning Rock Biotech Molecular Diagnosis of Tumors Introduction

11.10.4 Burning Rock Biotech Revenue in Molecular Diagnosis of Tumors Business (2020-2025)

11.10.5 Burning Rock Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Roche Holding

Thermo Fisher Scientific

Danaher Corporation

Veracyte, Inc.

TBG Diagnostics

Agilient Technologies

Illumina Inc

GENECAST

Burning Rock Biotech

List of Tables

Table 1. Global Molecular Diagnosis of Tumors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of NGS-Based

Table 3. Key Players of PCR-Based

Table 4. Global Molecular Diagnosis of Tumors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Molecular Diagnosis of Tumors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Molecular Diagnosis of Tumors Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Molecular Diagnosis of Tumors Market Share by Region (2020-2025)

Table 8. Global Molecular Diagnosis of Tumors Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Molecular Diagnosis of Tumors Market Share by Region (2026-2031)

Table 10. Molecular Diagnosis of Tumors Market Trends

Table 11. Molecular Diagnosis of Tumors Market Drivers

Table 12. Molecular Diagnosis of Tumors Market Challenges

Table 13. Molecular Diagnosis of Tumors Market Restraints

Table 14. Global Molecular Diagnosis of Tumors Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Molecular Diagnosis of Tumors Market Share by Players (2020-2025)

Table 16. Global Top Molecular Diagnosis of Tumors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Tumors as of 2024)

Table 17. Ranking of Global Top Molecular Diagnosis of Tumors Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Molecular Diagnosis of Tumors Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Molecular Diagnosis of Tumors, Headquarters and Area Served

Table 20. Global Key Players of Molecular Diagnosis of Tumors, Product and Application

Table 21. Global Key Players of Molecular Diagnosis of Tumors, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Molecular Diagnosis of Tumors Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Molecular Diagnosis of Tumors Revenue Market Share by Type (2020-2025)

Table 25. Global Molecular Diagnosis of Tumors Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Molecular Diagnosis of Tumors Revenue Market Share by Type (2026-2031)

Table 27. Global Molecular Diagnosis of Tumors Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Molecular Diagnosis of Tumors Revenue Market Share by Application (2020-2025)

Table 29. Global Molecular Diagnosis of Tumors Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Molecular Diagnosis of Tumors Revenue Market Share by Application (2026-2031)

Table 31. North America Molecular Diagnosis of Tumors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Molecular Diagnosis of Tumors Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Molecular Diagnosis of Tumors Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Molecular Diagnosis of Tumors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Molecular Diagnosis of Tumors Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Molecular Diagnosis of Tumors Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Molecular Diagnosis of Tumors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Molecular Diagnosis of Tumors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Molecular Diagnosis of Tumors Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Molecular Diagnosis of Tumors Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Molecular Diagnosis of Tumors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country (2026-2031) & (US$ Million)

Table 46. Abbott Laboratories Company Details

Table 47. Abbott Laboratories Business Overview

Table 48. Abbott Laboratories Molecular Diagnosis of Tumors Product

Table 49. Abbott Laboratories Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 50. Abbott Laboratories Recent Development

Table 51. Roche Holding Company Details

Table 52. Roche Holding Business Overview

Table 53. Roche Holding Molecular Diagnosis of Tumors Product

Table 54. Roche Holding Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 55. Roche Holding Recent Development

Table 56. Thermo Fisher Scientific Company Details

Table 57. Thermo Fisher Scientific Business Overview

Table 58. Thermo Fisher Scientific Molecular Diagnosis of Tumors Product

Table 59. Thermo Fisher Scientific Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 60. Thermo Fisher Scientific Recent Development

Table 61. Danaher Corporation Company Details

Table 62. Danaher Corporation Business Overview

Table 63. Danaher Corporation Molecular Diagnosis of Tumors Product

Table 64. Danaher Corporation Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 65. Danaher Corporation Recent Development

Table 66. Veracyte Company Details

Table 67. Veracyte Business Overview

Table 68. Veracyte Molecular Diagnosis of Tumors Product

Table 69. Veracyte Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 70. Veracyte Recent Development

Table 71. TBG Diagnostics Company Details

Table 72. TBG Diagnostics Business Overview

Table 73. TBG Diagnostics Molecular Diagnosis of Tumors Product

Table 74. TBG Diagnostics Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 75. TBG Diagnostics Recent Development

Table 76. Agilient Technologies Company Details

Table 77. Agilient Technologies Business Overview

Table 78. Agilient Technologies Molecular Diagnosis of Tumors Product

Table 79. Agilient Technologies Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 80. Agilient Technologies Recent Development

Table 81. Illumina Company Details

Table 82. Illumina Business Overview

Table 83. Illumina Molecular Diagnosis of Tumors Product

Table 84. Illumina Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 85. Illumina Recent Development

Table 86. Genecast Company Details

Table 87. Genecast Business Overview

Table 88. Genecast Molecular Diagnosis of Tumors Product

Table 89. Genecast Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 90. Genecast Recent Development

Table 91. Burning Rock Biotech Company Details

Table 92. Burning Rock Biotech Business Overview

Table 93. Burning Rock Biotech Molecular Diagnosis of Tumors Product

Table 94. Burning Rock Biotech Revenue in Molecular Diagnosis of Tumors Business (2020-2025) & (US$ Million)

Table 95. Burning Rock Biotech Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Molecular Diagnosis of Tumors Picture

Figure 2. Global Molecular Diagnosis of Tumors Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Molecular Diagnosis of Tumors Market Share by Type: 2024 VS 2031

Figure 4. NGS-Based Features

Figure 5. PCR-Based Features

Figure 6. Global Molecular Diagnosis of Tumors Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Molecular Diagnosis of Tumors Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Diagnostic Centers Case Studies

Figure 10. Others Case Studies

Figure 11. Molecular Diagnosis of Tumors Report Years Considered

Figure 12. Global Molecular Diagnosis of Tumors Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Molecular Diagnosis of Tumors Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Molecular Diagnosis of Tumors Market Share by Region: 2024 VS 2031

Figure 15. Global Molecular Diagnosis of Tumors Market Share by Players in 2024

Figure 16. Global Top Molecular Diagnosis of Tumors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Tumors as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Tumors Revenue in 2024

Figure 18. North America Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Molecular Diagnosis of Tumors Market Share by Country (2020-2031)

Figure 20. United States Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Molecular Diagnosis of Tumors Market Share by Country (2020-2031)

Figure 24. Germany Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Molecular Diagnosis of Tumors Market Share by Region (2020-2031)

Figure 32. China Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Molecular Diagnosis of Tumors Market Share by Country (2020-2031)

Figure 40. Mexico Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Molecular Diagnosis of Tumors Market Share by Country (2020-2031)

Figure 44. Turkey Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Molecular Diagnosis of Tumors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 48. Roche Holding Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 50. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 51. Veracyte Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 52. TBG Diagnostics Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 53. Agilient Technologies Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 54. Illumina Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 55. Genecast Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 56. Burning Rock Biotech Revenue Growth Rate in Molecular Diagnosis of Tumors Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oncology Based Molecular Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Diagnostic Guidewire Market Research Report 2024

Global Kidney Cancer Diagnosis Market Research Report 2025

Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Reproductive and Fertility Diagnosis Market Research Report 2025

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmacogenomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Image assisted Diagnosis Software Market Research Report 2025

Global Gynecological Cancers Drug Market Research Report 2025

Tissue Based Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Diagnostics Kits Market Insights Forecast to 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-27M19164

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Cancer Early Screening NGS Testing Platform Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29B19202

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Cancer Treatment Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I9425

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Global Checkpoint Inhibitors for Treating Cancer Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-25J2388

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Molecular Diagnosis of Tumors Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-38V13667

Global Molecular Diagnosis of Tumors Market Research Report 2025

FEATURED COMPANIES

Molecular Diagnosis of Tumors Market Size

Molecular Diagnosis of Tumors Market

Scope of Molecular Diagnosis of Tumors Market Report

Chapter Outline

FAQ for this report

How fast is Molecular Diagnosis of Tumors Market growing?

What is the Molecular Diagnosis of Tumors Market size in 2031?

Who are the main players in the Molecular Diagnosis of Tumors Market report?

What are the Application segmentation covered in the Molecular Diagnosis of Tumors Market report?

What are the Type segmentation covered in the Molecular Diagnosis of Tumors Market report?

FEATURED COMPANIES

RELATED REPORTS